BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 22, 2014
View Archived Issues
Scientists at University of North Carolina design novel Mer inhibitors
Read More
Vertex designs selective HSP inhibitors for neurodegenerative disorders
Read More
Synthetic MTDL as a novel therapeutic for ischemic stroke
Read More
Viral-induced overexpression of ITGA7 presented as a therapeutic approach for DMD
Read More
GSK's fluticasone plus umeclidinium combination safe in phase I trial
Read More
Bioequivalence study begins for Elite Pharmaceuticals' third opioid abuse deterrent drug
Read More
Clinical trial results presented for liraglutide for weight management and diabetes
Read More
Pharmaleads patents new mixed NEP/AP-N inhibitors
Read More
Novel dsRNA molecules divulged by PhaseRx
Read More
Genprex begins phase II trial of Oncoprex in lung cancer
Read More
Ceapro licenses dry powder formulation technology from University of Alberta
Read More
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical obtains Chinese clinical trial clearance
Read More
Terumo BCT and Kaneka collaborate on therapeutic apheresis and columns for LDL reduction
Read More
Cardio3 BioSciences enters agreement with ViroMed for use of C-Cathez in VM-202-CAD development
Read More
Proteo Biotech agrees to financing deal for orphan drug development
Read More
UCB invests in collaboration partner Beryllium
Read More
Sirona Biochem discloses cell protection agent
Read More
Japan Tobacco discloses new ROR-gamma antagonists
Read More
New BTK inhibitors patented by Roche
Read More
Japanese orphan drug designation for Edison's EPI-743 in Leigh syndrome
Read More
Summit reports results from phase Ib study of SMT-C1100 in pediatric DMD patients
Read More
GlycoMimetics receives payment from Pfizer in connection with phase III trial
Read More
aTyr Pharma completes first phase I study of Resokine
Read More
Baxter provides regulatory update on HyQvia
Read More
Antibe Therapeutics submits CTA for ATB-346
Read More
BioAlliance and Topotarget merge to form Onxeo
Read More